InsidersTradesSigma
Browse the complete record of transactions filed by Colgan Erin, Chief Financial Officer. Insider active across 1 companies, notably Sensei Biotherapeutics, Inc.. Aggregated, 1 filings have been recorded. The latest transaction was filed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Erin Colgan is the Chief Financial Officer at Sensei Biotherapeutics, Inc. She is responsible for the company's financial management, overseeing accounting and financial operations. Her role is essential in ensuring financial transparency and compliance with regulations.